Literature DB >> 11348604

Prognostic value of exercise echocardiography in patients after coronary artery bypass surgery.

A M Arruda1, R B McCully, J K Oh, D W Mahoney, J B Seward, P A Pellikka.   

Abstract

To assess the prognostic value of exercise echocardiography in patients with prior coronary artery bypass surgery, follow-up was obtained in 718 patients (591 men [82%] and 127 women [18%], aged 67 +/- 9 years) who underwent clinically indicated exercise echocardiography 5.7 +/- 4.7 years after coronary bypass surgery. Resting wall motion abnormalities were present in 479 patients (67%). New or worsening wall motion abnormalities developed with exercise in 366 patients (51%). During a median follow-up of 2.9 years, cardiac events included cardiac death in 36 patients and nonfatal myocardial infarction in 40 patients. The addition of the exercise echocardiographic variables, abnormal left ventricular end-systolic volume response and exercise ejection fraction to the clinical, resting echocardiographic and exercise electrocardiographic model provided incremental information in predicting cardiac events (chi-square 37 to chi-square 42, p = 0.02) and cardiac death (chi-square 38 to chi-square 43, p <0.02). Exercise echocardiography provides prognostic information in patients after coronary artery bypass surgery, incremental to clinical, rest echocardiographic, and exercise electrocardiographic variables.

Entities:  

Mesh:

Year:  2001        PMID: 11348604     DOI: 10.1016/s0002-9149(01)01463-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  Stress echocardiography for the detection and assessment of coronary artery disease.

Authors:  Nowell M Fine; Patricia A Pellikka
Journal:  J Nucl Cardiol       Date:  2011-05       Impact factor: 5.952

2.  Size, shape, and stamina: the impact of left ventricular geometry on exercise capacity.

Authors:  Carolyn S P Lam; Jasmine Grewal; Barry A Borlaug; Steve R Ommen; Garvan C Kane; Robert B McCully; Patricia A Pellikka
Journal:  Hypertension       Date:  2010-03-09       Impact factor: 10.190

3.  Prognostic value of dobutamine stress echocardiography in patients with previous coronary revascularisation.

Authors:  M Bountioukos; A Elhendy; R T van Domburg; A F L Schinkel; J J Bax; B J Krenning; E Biagini; V Rizzello; M L Simoons; D Poldermans
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

4.  Increase in end-systolic volume after exercise independently predicts mortality in patients with coronary heart disease: data from the Heart and Soul Study.

Authors:  Mintu P Turakhia; David D McManus; Mary A Whooley; Nelson B Schiller
Journal:  Eur Heart J       Date:  2009-07-03       Impact factor: 29.983

5.  Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study.

Authors:  Joachim H Ix; Michael G Shlipak; Haiying H Liu; Nelson B Schiller; Mary A Whooley
Journal:  J Am Soc Nephrol       Date:  2003-12       Impact factor: 10.121

6.  Practical guidance for the implementation of stress echocardiography.

Authors:  Kengo Suzuki; Yutaka Hirano; Hirotsugu Yamada; Mitsushige Murata; Masao Daimon; Masaaki Takeuchi; Yoshihiro Seo; Chisato Izumi; Makoto Akaishi
Journal:  J Echocardiogr       Date:  2018-06-06

Review 7.  Non-invasive Ischaemia Testing in Patients With Prior Coronary Artery Bypass Graft Surgery: Technical Challenges, Limitations, and Future Directions.

Authors:  Andreas Seraphim; Kristopher D Knott; Joao B Augusto; Katia Menacho; Sara Tyebally; Benjamin Dowsing; Sanjeev Bhattacharyya; Leon J Menezes; Daniel A Jones; Rakesh Uppal; James C Moon; Charlotte Manisty
Journal:  Front Cardiovasc Med       Date:  2021-12-23

8.  Stress echocardiography and major cardiac events in patients with normal exercise test.

Authors:  Flávia Ricci Calasans; Bruno Fernandes de Oliveira Santos; Débora Consuelo Rocha Silveira; Ana Carla Pereira de Araújo; Luiza Dantas Melo; José Augusto Barreto-Filho; Antônio Carlos Sobral Sousa; Joselina Luzia Menezes Oliveira
Journal:  Arq Bras Cardiol       Date:  2013-06-14       Impact factor: 2.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.